Head of Canada’s drug price regulator resigns same week as colleague steps down

  • 📰 globeandmail
  • ⏱ Reading Time:
  • 32 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 92%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Douglas Clark, executive director of the Patented Medicine Prices Review Board, announced today he will be leaving his post after almost a decade with the regulator

On Thursday, Matthew Herder, a professor of health law at Dalhousie University, announced he had resigned from the board, accusing the federal government of failing to implement critically important reforms that would lower the cost of medication.

Herder said in his resignation letter addressed to federal Health Minister Jean-Yves Duclos that he is stepping down because he no longer believes it is possible to serve the public good in this role, which he had held since 2018. Herder responded today on social media to news of Clark’s resignation, calling it an immense and irreplaceable loss.

Clark has agreed to remain with the board as a special adviser for an unspecified amount of time, and the board says work to appoint Clark’s successor will be launched soon.This story was produced with the financial assistance of the Meta and Canadian Press News Fellowship.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 5. in HEALTH

Health Health Latest News, Health Health Headlines